​

Tango Therapeutics (TNGX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Tango Therapeutics Revenue Highlights

Latest Revenue (Y)

$42.07M

Latest Revenue (Q)

$5.39M

Main Segment (Y)

Collaboration Revenue

Main Geography (Y)

Collaboration Revenue

Tango Therapeutics Revenue by Period

Tango Therapeutics Revenue by Year

DateRevenueChange
2024-12-31$42.07M15.17%
2023-12-31$36.53M46.93%
2022-12-31$24.86M-32.89%
2021-12-31$37.04M383.83%
2020-12-31$7.66M-68.94%
2019-12-31$24.65M-

Tango Therapeutics generated $42.07M in revenue during NA 2024, up 15.17% compared to the previous quarter, and up 170.67% compared to the same period a year ago.

Tango Therapeutics Revenue by Quarter

DateRevenueChange
2025-03-31$5.39M30.97%
2024-12-31$4.12M-64.53%
2024-09-30$11.61M-41.60%
2024-06-30$19.88M207.14%
2024-03-31$6.47M19.15%
2023-12-31$5.43M-49.39%
2023-09-30$10.73M-26.48%
2023-06-30$14.60M153.17%
2023-03-31$5.77M-10.06%
2022-12-31$6.41M-7.36%
2022-09-30$6.92M19.91%
2022-06-30$5.77M0.23%
2022-03-31$5.76M0.73%
2021-12-31$5.72M-15.78%
2021-09-30$6.79M-62.61%
2021-06-30$18.15M184.26%
2021-03-31$6.39M-30.15%
2020-12-31$9.14M-181.18%
2020-09-30$-11.26M-322.37%
2020-06-30$5.06M7.49%
2020-03-31$4.71M-

Tango Therapeutics generated $5.39M in revenue during Q1 2025, up 30.97% compared to the previous quarter, and up 99.28% compared to the same period a year ago.

Tango Therapeutics Revenue Breakdown

Tango Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21
Collaboration Revenue$29.97M$31.53M$24.86M$26.04M
License Revenue$12.10M$5.00M$11.00M-

Tango Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 24: Collaboration Revenue (71.24%), and License Revenue (28.76%).

Quarterly Revenue by Product

Product/ServiceMar 25Dec 24Sep 24Dec 23Sep 23Jun 23Dec 22Sep 22Jun 22Dec 21Sep 21
Collaboration Revenue$5.39M$18.36M$11.61M$11.20M$10.73M$9.60M$6.41M$6.92M$5.77M$5.72M$6.79M
License Revenue--$12.10M-$5.00M$5.00M-$11.00M---

Tango Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Collaboration Revenue (100.00%).

Tango Therapeutics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 22Dec 21
Collaboration Revenue$24.86M$26.04M
License Revenue-$11.00M

Tango Therapeutics's latest annual revenue breakdown by geography, as of Dec 22: Collaboration Revenue (100.00%).

Tango Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ARVNArvinas$263.40M$188.80M
GLUEMonte Rosa Therapeutics$75.62M$60.65M
NRIXNurix Therapeutics$54.55M$18.45M
KYMRKymera Therapeutics$47.07M$7.39M
TNGXTango Therapeutics$42.07M$5.39M
STOKStoke Therapeutics$36.55M$22.61M
CNTBConnect Biopharma$26.03M-
FHTXFoghorn Therapeutics$22.60M$2.86M
RLAYRelay Therapeutics$10.01M$7.68M
XLOXilio Therapeutics$6.34M$1.72M
STTKShattuck Labs$5.72M-
RLYBRallybio$636.00K$38.00K
CGEMCullinan Oncology--
RAPTRAPT Therapeutics--
BDTXBlack Diamond Therapeutics--
RVMDRevolution Medicines--
EWTXEdgewise Therapeutics--
MLYSMineralys Therapeutics--
THRDThird Harmonic Bio--
PLRXPliant Therapeutics--
PASGPassage Bio--
TYRATyra Biosciences--

TNGX Revenue FAQ

What is Tango Therapeutics’s yearly revenue?

Tango Therapeutics's yearly revenue for 2024 was $42.07M, representing an increase of 15.17% compared to 2023. The company's yearly revenue for 2023 was $36.53M, representing an increase of 46.93% compared to 2022. TNGX's yearly revenue for 2022 was $24.86M, representing a decrease of -32.89% compared to 2021.

What is Tango Therapeutics’s quarterly revenue?

Tango Therapeutics's quarterly revenue for Q1 2025 was $5.39M, a 30.97% increase from the previous quarter (Q4 2024), and a -16.67% decrease year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $4.12M, a -64.53% decrease from the previous quarter (Q3 2024), and a -24.19% decrease year-over-year (Q4 2023). TNGX's quarterly revenue for Q3 2024 was $11.61M, a -41.60% decrease from the previous quarter (Q2 2024), and a 8.15% increase year-over-year (Q3 2023).

What is Tango Therapeutics’s revenue growth rate?

Tango Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 69.22%, and for the last 5 years (2020-2024) was 449.49%.

What are Tango Therapeutics’s revenue streams?

Tango Therapeutics's revenue streams in c 24 are Collaboration Revenue, and License Revenue. Collaboration Revenue generated $29.97M in revenue, accounting 71.24% of the company's total revenue, down -4.94% year-over-year. License Revenue generated $12.1M in revenue, accounting 28.76% of the company's total revenue, up 142.00% year-over-year.

What is Tango Therapeutics’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Tango Therapeutics was Collaboration Revenue. This segment made a revenue of $29.97M, representing 71.24% of the company's total revenue.